These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2124941)

  • 1. Histopathological effects and recovery rate of rat bladders following intravesical instillation of thiotepa, doxorubicin and mitomycin C.
    Chang SY; Yu DS; Wang J; Ma CP
    Br J Urol; 1990 Dec; 66(6):623-7. PubMed ID: 2124941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intravesical instillations of thiotepa, mitomycin C, and adriamycin on normal urothelium: an experimental study in rats.
    Friedman D; Mooppan UM; Rosen Y; Kim H
    J Urol; 1991 May; 145(5):1060-3. PubMed ID: 1901918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of thiotepa, mitomycin C, BCG and interferon instillation on urothelium.
    Polat O; Gündoğdu C; Demirel A; Bayraktar Y; Gül O; Ozbilge M
    Int Urol Nephrol; 1996; 28(1):43-8. PubMed ID: 8738618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder epithelial hyperplasia in F344 rats after intravesical instillation of the antitumor chemotherapeutic agents Adriamycin and mitomycin C.
    Shibata MA; Hasegawa R; Kurata Y; Yamada M; Tamano S; Fukushima S
    Cancer Lett; 1990 Jan; 49(1):41-9. PubMed ID: 2105835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single and sequential combination intravesical chemotherapy of murine bladder cancer.
    Soloway MS; Nissenkorn I; McCallum LW; Murphy WM
    Urology; 1982 Feb; 19(2):169-75. PubMed ID: 6800090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Urol Clin North Am; 1984 Nov; 11(4):623-35. PubMed ID: 6438857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder damage in mice after single and repeated intravesical instillations of mitomycin C or doxorubicin.
    Post JG; te Poele JA; Oussoren Y; Stewart FA
    J Urol; 1993 Dec; 150(6):1965-9. PubMed ID: 8230546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical chemotherapy--frequency of instillation.
    Smith PH
    Prog Clin Biol Res; 1985; 185B():57-68. PubMed ID: 3929271
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.
    Walker MC; Masters JR; Parris CN; Hepburn PJ; English PJ
    Urol Res; 1986; 14(3):137-40. PubMed ID: 3092427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitomycin C and epirubicin: functional bladder damage in rats after repeat intravesical instillations.
    Michielsen D; Amy JJ; Coomans D; Storme G; Wyndaele JJ
    J Urol; 2005 Jun; 173(6):2166-70. PubMed ID: 15879880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC; Loening SA; Narayana AS; Culp DA
    Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic agents: intravesical instillation.
    Brixey MT
    Urol Nurs; 1988; 9(2):4-6. PubMed ID: 3145560
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study.
    Heney NM; Koontz WW; Barton B; Soloway M; Trump DL; Hazra T; Weinstein RS
    J Urol; 1988 Dec; 140(6):1390-3. PubMed ID: 3143016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravesical chemotherapy for superficial bladder tumors].
    Ohmori H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS; Jordan AM; Murphy WM
    Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical therapy for bladder cancer.
    Soloway MS
    Urol Clin North Am; 1988 Nov; 15(4):661-9. PubMed ID: 3142129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical single and combination therapy in superficial bladder cancer. An experimental study.
    Rübben H; Dahm HH; von Uelft W; Rüttgers L; Friedrichs R; Lutzeyer W
    Eur Urol; 1982; 8(5):284-90. PubMed ID: 7117342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
    Groos E; Masters JR
    J Urol; 1986 Aug; 136(2):399-402. PubMed ID: 3090275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravesical instillation of antitumor chemotherapeutic agents on bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ohtani M; Fukushima S; Okamura T; Sakata T; Ito N; Koiso K; Niijima T
    Cancer; 1984 Oct; 54(8):1525-9. PubMed ID: 6434176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of interferon in combination with cytotoxic drugs on mouse bladder tumor (MBT-2) growth in vitro and in vivo.
    Bahnson R; Ratliff TL
    J Urol; 1988 Sep; 140(3):656-9. PubMed ID: 2457714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.